These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 1908655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical results of intraperitoneal hyperthermic perfusion combined with surgery in patients with peritoneal recurrence from gastric cancer].
    Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Okui K.
    Nihon Geka Gakkai Zasshi; 1990 Feb; 91(2):201-5. PubMed ID: 2109177
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma.
    Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T.
    Cancer; 1999 Feb 01; 85(3):529-34. PubMed ID: 10091726
    [Abstract] [Full Text] [Related]

  • 8. [Clinical result of intraperitoneal hyperthermic chemoperfusion for gastric cancer with serosal invasion to prevent peritoneal recurrence].
    Kobayashi K, Fujimoto S, Takahashi M, Muto T, Toyosawa T.
    Gan To Kagaku Ryoho; 1998 Jul 01; 25(9):1436-8. PubMed ID: 9703847
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.
    Kaibara N, Hamazoe R, Iitsuka Y, Maeta M, Koga S.
    Hepatogastroenterology; 1989 Apr 01; 36(2):75-8. PubMed ID: 2499527
    [Abstract] [Full Text] [Related]

  • 11. [A case of disappearance of peritoneal dissemination in gastric cancer induced by continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C].
    Fujimura T, Yonemura Y, Urade M, Sugiyama K, Hasegawa H, Hashimoto T, Miyata R, Matsuda Y, Katayama K, Yamaguchi A.
    Gan To Kagaku Ryoho; 1988 Aug 01; 15(8):2331-4. PubMed ID: 3136703
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of scald injury due to intraperitoneal hyperthermic perfusion for far-advanced gastric cancer].
    Kokubun M, Fujimoto S, Shrestha RD, Kobayashi K, Kiuchi S, Konno C, Ohta M, Takahashi M.
    Gan To Kagaku Ryoho; 1991 Aug 01; 18(11):2058-62. PubMed ID: 1877849
    [Abstract] [Full Text] [Related]

  • 13. [Total body hyperthermia and continuous hyperthermic peritoneal perfusion as an adjuvant therapy in advanced gastric cancer].
    Sugiyama Y, Suzuki H, Hada R, Miyagishima K, Yokoyama M, Daidouji K, Murata A, Yamazaki S, Mikami Y, Ozawa M.
    Gan To Kagaku Ryoho; 1991 Apr 01; 18(4):619-24. PubMed ID: 1901477
    [Abstract] [Full Text] [Related]

  • 14. Combined treatment with surgery and intraperitoneal hyperthermic perfusion (IPHP) for far-advanced gastrointestinal cancer with peritoneal seeding.
    Fujimoto S, Shrestha RD, Kobayashi K, Koike S, Kokubun M, Kiuchi S, Takahashi M, Konno C, Okui K.
    Acta Med Austriaca; 1989 Apr 01; 16(3-4):76-80. PubMed ID: 2609917
    [Abstract] [Full Text] [Related]

  • 15. [Continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C for peritoneal dissemination in gastric cancer].
    Fujimura T, Yonemura Y, Urade M, Sugiyama K, Hasegawa H, Hashimoto T, Miyata R, Matsuda Y, Katayama K, Yamaguchi A.
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul 20; 24(7):1415-24. PubMed ID: 2509604
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic analysis in intraperitoneal hyperthermic chemotherapy of far-advanced gastric cancer patients.
    Kobayashi K, Fujimoto S, Shrestha RD, Kokubun M, Kikuchi S, Konno C, Ohta M, Takahashi M, Okui K.
    Gan No Rinsho; 1989 Aug 20; 35(9):1016-20. PubMed ID: 2504971
    [Abstract] [Full Text] [Related]

  • 17. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer.
    Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Ohta M, Takahashi M, Kitsukawa Y, Mizutani M.
    Ann Surg; 1990 Nov 20; 212(5):592-6. PubMed ID: 2241314
    [Abstract] [Full Text] [Related]

  • 18. Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis.
    Fujimoto S, Takahashi M, Kobayashi K, Nagano K, Kure M, Mutoh T, Ohkubo H.
    Cancer; 1992 Dec 15; 70(12):2754-60. PubMed ID: 1451051
    [Abstract] [Full Text] [Related]

  • 19. [Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer].
    Iwamoto A, Takahashi T, Sasabe T, Itoh M, Kondoh S, Seiki K, Yoneyama C, Shimotsuma M, Hagiwara A, Yamaguchi T.
    Gan To Kagaku Ryoho; 1989 Aug 15; 16(8 Pt 2):2748-51. PubMed ID: 2506820
    [Abstract] [Full Text] [Related]

  • 20. Clinical trial with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer.
    Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Takahashi M, Konno C, Ohta M, Koike S, Kitsukawa Y.
    Cancer; 1989 Jul 01; 64(1):154-60. PubMed ID: 2499413
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.